DEEP Measures is a digital measures company accelerating drug development by helping pharmaceutical and clinical research organizations define, validate, and gain regulatory acceptance for digital health technologies – from wearable sensors and connected devices to digital biomarkers and patient-reported outcomes captured through technology.
Founded in 2022 and spun out of Johnson & Johnson, DEEP provides the missing scientific and regulatory layer that makes digital health technology data trustworthy and submission-ready. Our platform combines a curated catalogue of reusable digital measure building blocks, structured collaboration workspaces, and expert services – underpinned by proprietary regulatory science and deep domain expertise.
As a registered SME with the European Medicines Agency, DEEP has direct experience with formal regulatory qualification pathways and is actively engaged with both the EMA and FDA on advancing acceptance of digital endpoints.
DEEP is headquartered in Helsinki, with a dedicated US team in place to support its growing base of US-based customers and partners.